Norges Bank’s MacroGenics MGNX Stock Holding History

Norges Bank’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-50,958	Closed	-$1.17M	–	2173
2020 Q4	$1.17M	Hold	50,958	–	–	﹤0.01%	2013
2020 Q3	$1.28M	Buy	+50,958	New	+$1.39M	﹤0.01%	2009

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Norges Bank's MGNX Position: Q1 2021 in Review

Norges Bank sold out of MacroGenics (MGNX) in Q1 2021, closing a stake of 50,958 shares — an estimated $1.17M sold.

Norges Bank first reported a position in MGNX in Q3 2020 and held it in 2 quarters. The position peaked at $1.28M in Q3 2020. 173 funds tracked by Wall St. Rank hold MGNX as of Q1 2021.

Norges Bank reported no remaining MacroGenics position as of Q1 2021 after selling out during the quarter.
Norges Bank sold 50,958 MacroGenics shares in Q1 2021, an estimated $1.17M.
Norges Bank first reported a position in MacroGenics in Q3 2020 and held it in 2 quarters.
Norges Bank's MacroGenics position peaked at $1.28M in Q3 2020.
173 funds tracked by Wall St. Rank held MacroGenics as of Q1 2021.

Based on Norges Bank's 13F filing for Q1 2021, filed 7 May 2021.